ID   EPHA1_HUMAN             Reviewed;         976 AA.
AC   P21709; A1L3V3; B5A966; B5A967; Q15405;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   10-MAY-2017, entry version 192.
DE   RecName: Full=Ephrin type-A receptor 1;
DE            Short=hEpha1;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH tyrosine kinase;
DE   AltName: Full=EPH tyrosine kinase 1;
DE   AltName: Full=Erythropoietin-producing hepatoma receptor;
DE   AltName: Full=Tyrosine-protein kinase receptor EPH;
DE   Flags: Precursor;
GN   Name=EPHA1; Synonyms=EPH, EPHT, EPHT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ALA-160 AND
RP   VAL-900.
RX   PubMed=2825356; DOI=10.1126/science.2825356;
RA   Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F.;
RT   "A novel putative tyrosine kinase receptor encoded by the eph gene.";
RL   Science 238:1717-1720(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-160 AND VAL-900.
RX   PubMed=10369740; DOI=10.1006/mcpr.1999.0228;
RA   Owshalimpur D., Kelley M.J.;
RT   "Genomic structure of the EPHA1 receptor tyrosine kinase gene.";
RL   Mol. Cell. Probes 13:169-173(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS ALA-160
RP   AND VAL-900.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS ALA-160
RP   AND VAL-900.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ALA-160 AND VAL-900.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 286-976 (ISOFORM 1), AND VARIANT
RP   VAL-900.
RC   TISSUE=Placenta;
RA   Tuzi N.L.;
RT   "An EGFR/eph chimeric receptor possesses ligand stimulated tyrosine
RT   kinase activity and promotes cell growth.";
RL   Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NOMENCLATURE.
RX   PubMed=9267020;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [10]
RP   FUNCTION IN MIGRATION OF T-LYMPHOCYTES, AND INTERACTION WITH LCK;
RP   PTK2B/PYK2 AND PI3-KINASE.
RX   PubMed=17634955; DOI=10.1002/eji.200737111;
RA   Hjorthaug H.S., Aasheim H.C.;
RT   "Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes.";
RL   Eur. J. Immunol. 37:2326-2336(2007).
RN   [11]
RP   FUNCTION IN CELL SPREADING, FUNCTION IN CELL MIGRATION,
RP   AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   PTK2/FAK1 AND ILK.
RX   PubMed=19118217; DOI=10.1242/jcs.036467;
RA   Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y.;
RT   "EphA1 interacts with integrin-linked kinase and regulates cell
RT   morphology and motility.";
RL   J. Cell Sci. 122:243-255(2009).
RN   [12]
RP   FUNCTION IN ANGIOGENESIS, AND FUNCTION IN CELL PROLIFERATION.
RX   PubMed=20043122;
RA   Chen G., Wang Y., Zhou M., Shi H., Yu Z., Zhu Y., Yu F.;
RT   "EphA1 receptor silencing by small interfering RNA has antiangiogenic
RT   and antitumor efficacy in hepatocellular carcinoma.";
RL   Oncol. Rep. 23:563-570(2010).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-
RT   translational modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND SER-910, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   STRUCTURE BY NMR OF 536-573, AND HOMODIMERIZATION.
RX   PubMed=18728013; DOI=10.1074/jbc.M803089200;
RA   Bocharov E.V., Mayzel M.L., Volynsky P.E., Goncharuk M.V.,
RA   Ermolyuk Y.S., Schulga A.A., Artemenko E.O., Efremov R.G.,
RA   Arseniev A.S.;
RT   "Spatial structure and pH-dependent conformational diversity of
RT   dimeric transmembrane domain of the receptor tyrosine kinase EphA1.";
RL   J. Biol. Chem. 283:29385-29395(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 911-974.
RG   Structural genomics consortium (SGC);
RT   "Sam domain of human ephrin type-a receptor 1 (epha1).";
RL   Submitted (JUN-2009) to the PDB data bank.
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-160; CYS-351; GLN-492; GLN-575;
RP   THR-585; LEU-697; LYS-703; ARG-807 AND VAL-900.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-900, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
CC   -!- FUNCTION: Receptor tyrosine kinase which binds promiscuously
CC       membrane-bound ephrin-A family ligands residing on adjacent cells,
CC       leading to contact-dependent bidirectional signaling into
CC       neighboring cells. The signaling pathway downstream of the
CC       receptor is referred to as forward signaling while the signaling
CC       pathway downstream of the ephrin ligand is referred to as reverse
CC       signaling. Binds with a low affinity EFNA3 and EFNA4 and with a
CC       high affinity to EFNA1 which most probably constitutes its
CC       cognate/functional ligand. Upon activation by EFNA1 induces cell
CC       attachment to the extracellular matrix inhibiting cell spreading
CC       and motility through regulation of ILK and downstream RHOA and
CC       RAC. Plays also a role in angiogenesis and regulates cell
CC       proliferation. May play a role in apoptosis.
CC       {ECO:0000269|PubMed:17634955, ECO:0000269|PubMed:19118217,
CC       ECO:0000269|PubMed:20043122}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- SUBUNIT: Homodimer. Forms a signaling complex with LCK; PTK2B/PYK2
CC       and PI3-kinase upon activation by EFNA1; regulates T-lymphocytes
CC       migration. Interacts (via SAM domain) with ILK (via ANK repeats);
CC       stimulated by EFNA1 but independent of the kinase activity of
CC       EPHA1. Interacts (kinase activity-dependent) with PTK2/FAK1.
CC       {ECO:0000269|PubMed:17634955, ECO:0000269|PubMed:19118217}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19118217};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:19118217}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P21709-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21709-2; Sequence=VSP_056010, VSP_056013;
CC       Name=3;
CC         IsoId=P21709-3; Sequence=VSP_056011, VSP_056012;
CC   -!- TISSUE SPECIFICITY: Overexpressed in several carcinomas.
CC   -!- PTM: Phosphorylated. Autophosphorylation is stimulated by its
CC       ligand EFNA1.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20596523}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36747.1; Type=Frameshift; Positions=582, 595, 601; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EPHA1ID40461ch7q35.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18391; AAA36747.1; ALT_FRAME; mRNA.
DR   EMBL; AF101171; AAD43440.1; -; Genomic_DNA.
DR   EMBL; AF101165; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101166; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101167; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101168; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101169; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; AF101170; AAD43440.1; JOINED; Genomic_DNA.
DR   EMBL; EU826604; ACF47640.1; -; mRNA.
DR   EMBL; EU826605; ACF47641.1; -; mRNA.
DR   EMBL; AC092214; AAS07458.1; -; Genomic_DNA.
DR   EMBL; CH236959; EAL23789.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51846.1; -; Genomic_DNA.
DR   EMBL; CH471198; EAW51847.1; -; Genomic_DNA.
DR   EMBL; BC130291; AAI30292.1; -; mRNA.
DR   EMBL; Z27409; CAA81796.1; -; mRNA.
DR   CCDS; CCDS5884.1; -. [P21709-1]
DR   PIR; A34076; A34076.
DR   RefSeq; NP_005223.4; NM_005232.4. [P21709-1]
DR   UniGene; Hs.89839; -.
DR   PDB; 2K1K; NMR; -; A/B=536-573.
DR   PDB; 2K1L; NMR; -; A/B=536-573.
DR   PDB; 3HIL; X-ray; 2.00 A; A/B=911-974.
DR   PDB; 3KKA; X-ray; 2.40 A; A/B=911-974.
DR   PDBsum; 2K1K; -.
DR   PDBsum; 2K1L; -.
DR   PDBsum; 3HIL; -.
DR   PDBsum; 3KKA; -.
DR   ProteinModelPortal; P21709; -.
DR   SMR; P21709; -.
DR   BioGrid; 108355; 70.
DR   DIP; DIP-34886N; -.
DR   IntAct; P21709; 6.
DR   STRING; 9606.ENSP00000275815; -.
DR   BindingDB; P21709; -.
DR   ChEMBL; CHEMBL5810; -.
DR   GuidetoPHARMACOLOGY; 1821; -.
DR   iPTMnet; P21709; -.
DR   PhosphoSitePlus; P21709; -.
DR   BioMuta; EPHA1; -.
DR   DMDM; 317373566; -.
DR   EPD; P21709; -.
DR   MaxQB; P21709; -.
DR   PaxDb; P21709; -.
DR   PeptideAtlas; P21709; -.
DR   PRIDE; P21709; -.
DR   DNASU; 2041; -.
DR   Ensembl; ENST00000275815; ENSP00000275815; ENSG00000146904. [P21709-1]
DR   GeneID; 2041; -.
DR   KEGG; hsa:2041; -.
DR   UCSC; uc003wcz.3; human. [P21709-1]
DR   CTD; 2041; -.
DR   DisGeNET; 2041; -.
DR   GeneCards; EPHA1; -.
DR   H-InvDB; HIX0033699; -.
DR   HGNC; HGNC:3385; EPHA1.
DR   HPA; CAB026144; -.
DR   MIM; 179610; gene.
DR   neXtProt; NX_P21709; -.
DR   OpenTargets; ENSG00000146904; -.
DR   PharmGKB; PA27817; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOGENOM; HOG000233856; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P21709; -.
DR   KO; K05102; -.
DR   OMA; QAYEDPA; -.
DR   OrthoDB; EOG091G00W0; -.
DR   PhylomeDB; P21709; -.
DR   TreeFam; TF315363; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-2892247; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; P21709; -.
DR   SIGNOR; P21709; -.
DR   ChiTaRS; EPHA1; human.
DR   EvolutionaryTrace; P21709; -.
DR   GeneWiki; EPH_receptor_A1; -.
DR   GenomeRNAi; 2041; -.
DR   PRO; PR:P21709; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146904; -.
DR   CleanEx; HS_EPHA1; -.
DR   Genevisible; P21709; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0090630; P:activation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:UniProtKB.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; TAS:Reactome.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; IDA:UniProtKB.
DR   CDD; cd10479; EphR_LBD_A1; 1.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR034251; EphA1_rcpt_lig-bd.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Angiogenesis; ATP-binding;
KW   Cell adhesion; Cell membrane; Complete proteome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Repeat; Signal; Transferase; Transmembrane;
KW   Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    976       Ephrin type-A receptor 1.
FT                                /FTId=PRO_0000016798.
FT   TOPO_DOM     26    547       Extracellular. {ECO:0000255}.
FT   TRANSMEM    548    568       Helical. {ECO:0000255}.
FT   TOPO_DOM    569    976       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       27    209       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      332    445       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      447    538       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      624    884       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      913    976       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   NP_BIND     630    638       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       974    976       PDZ-binding. {ECO:0000255}.
FT   COMPBIAS    191    329       Cys-rich.
FT   ACT_SITE    749    749       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     656    656       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     599    599       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     605    605       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     781    781       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   MOD_RES     906    906       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     910    910       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     930    930       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     446    490       ESLSGLSLRLVKKEPRQLELTWAGSRPRSPGANLTYELHVL
FT                                NQDE -> DPTLSLWTPRVTVRPVSETGEERTEATRADLGG
FT                                VPAPKPWGEPDL (in isoform 2).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_056010.
FT   VAR_SEQ     446    474       ESLSGLSLRLVKKEPRQLELTWAGSRPRS -> GERLRGAG
FT                                TGTWWRQKGLRPQNKLMGRKP (in isoform 3).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_056011.
FT   VAR_SEQ     475    976       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_056012.
FT   VAR_SEQ     491    976       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_056013.
FT   VARIANT     160    160       V -> A (in dbSNP:rs4725617).
FT                                {ECO:0000269|PubMed:10369740,
FT                                ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2825356,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_028265.
FT   VARIANT     351    351       R -> C (in dbSNP:rs56006153).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042115.
FT   VARIANT     492    492       R -> Q (in dbSNP:rs11768549).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028266.
FT   VARIANT     575    575       R -> Q (in dbSNP:rs35719334).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042116.
FT   VARIANT     585    585       A -> T (in dbSNP:rs34178823).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042117.
FT   VARIANT     697    697       P -> L (in dbSNP:rs34372369).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042118.
FT   VARIANT     703    703       E -> K (in a breast pleomorphic lobular
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042119.
FT   VARIANT     807    807       S -> R (in dbSNP:rs56244405).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042120.
FT   VARIANT     900    900       M -> V (in dbSNP:rs6967117).
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:10369740,
FT                                ECO:0000269|PubMed:12690205,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:2825356,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_028267.
FT   CONFLICT    398    398       G -> A (in Ref. 2; AAD43440 and 8;
FT                                CAA81796). {ECO:0000305}.
FT   STRAND      538    540       {ECO:0000244|PDB:2K1K}.
FT   HELIX       545    570       {ECO:0000244|PDB:2K1K}.
FT   HELIX       918    924       {ECO:0000244|PDB:3HIL}.
FT   HELIX       928    930       {ECO:0000244|PDB:3HIL}.
FT   HELIX       931    936       {ECO:0000244|PDB:3HIL}.
FT   HELIX       942    945       {ECO:0000244|PDB:3HIL}.
FT   HELIX       950    955       {ECO:0000244|PDB:3HIL}.
FT   HELIX       961    973       {ECO:0000244|PDB:3HIL}.
SQ   SEQUENCE   976 AA;  108127 MW;  91EFCA69FFE17826 CRC64;
     MERRWPLGLG LVLLLCAPLP PGARAKEVTL MDTSKAQGEL GWLLDPPKDG WSEQQQILNG
     TPLYMYQDCP MQGRRDTDHW LRSNWIYRGE EASRVHVELQ FTVRDCKSFP GGAGPLGCKE
     TFNLLYMESD QDVGIQLRRP LFQKVTTVAA DQSFTIRDLV SGSVKLNVER CSLGRLTRRG
     LYLAFHNPGA CVALVSVRVF YQRCPETLNG LAQFPDTLPG PAGLVEVAGT CLPHARASPR
     PSGAPRMHCS PDGEWLVPVG RCHCEPGYEE GGSGEACVAC PSGSYRMDMD TPHCLTCPQQ
     STAESEGATI CTCESGHYRA PGEGPQVACT GPPSAPRNLS FSASGTQLSL RWEPPADTGG
     RQDVRYSVRC SQCQGTAQDG GPCQPCGVGV HFSPGARGLT TPAVHVNGLE PYANYTFNVE
     AQNGVSGLGS SGHASTSVSI SMGHAESLSG LSLRLVKKEP RQLELTWAGS RPRSPGANLT
     YELHVLNQDE ERYQMVLEPR VLLTELQPDT TYIVRVRMLT PLGPGPFSPD HEFRTSPPVS
     RGLTGGEIVA VIFGLLLGAA LLLGILVFRS RRAQRQRQQR QRDRATDVDR EDKLWLKPYV
     DLQAYEDPAQ GALDFTRELD PAWLMVDTVI GEGEFGEVYR GTLRLPSQDC KTVAIKTLKD
     TSPGGQWWNF LREATIMGQF SHPHILHLEG VVTKRKPIMI ITEFMENGAL DAFLREREDQ
     LVPGQLVAML QGIASGMNYL SNHNYVHRDL AARNILVNQN LCCKVSDFGL TRLLDDFDGT
     YETQGGKIPI RWTAPEAIAH RIFTTASDVW SFGIVMWEVL SFGDKPYGEM SNQEVMKSIE
     DGYRLPPPVD CPAPLYELMK NCWAYDRARR PHFQKLQAHL EQLLANPHSL RTIANFDPRM
     TLRLPSLSGS DGIPYRTVSE WLESIRMKRY ILHFHSAGLD TMECVLELTA EDLTQMGITL
     PGHQKRILCS IQGFKD
//
